Literature DB >> 14698800

Twelve-month maintenance treatment of opium-dependent patients.

Jamshid Ahmadi1, Mohammadali Babaee-Beigi, Mohammadjavad Alishahi, Iraj Maany, Taghi Hidari.   

Abstract

The goal of this study was to compare the effects of 1, 3 and 8 mg per day doses of buprenorphine in the maintenance treatment of opium-dependent subjects in Iran over a treatment period of 12 months. Participants were randomized to three equal groups (171 subjects per group) of opium-dependent individuals who met the DSM-IV criteria for opioid dependence and were seeking treatment. They were treated in an urban outpatient clinic, offering a 1-hour weekly individual counseling session. Overall, 282 subjects (55%) completed the 12 months study. Completion rates by dosage group were 46 (26.9%) for the 1 mg dose group, 102 (59.6%) for the 3 mg dose group, and 134 (78.4%) for the 8 mg dose group (p =.000). These findings are consistent with previous reports of effective buprenorphine use in western countries as a suitable maintenance treatment for opium dependence.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14698800     DOI: 10.1016/s0740-5472(03)00141-7

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  7 in total

Review 1.  The pharmacological treatment of opioid addiction--a clinical perspective.

Authors:  Philipp Lobmaier; Michael Gossop; Helge Waal; Jorgen Bramness
Journal:  Eur J Clin Pharmacol       Date:  2010-02-19       Impact factor: 2.953

2.  Prevalence of dyslipidemia and its association with opium consumption in the Rafsanjan cohort study.

Authors:  Zahra Jamali; Mojgan Noroozi Karimabad; Parvin Khalili; Tabandeh Sadeghi; Ahmadreza Sayadi; Faegheh Mohammadakbari Rostamabadi; Carlo La Vecchia; Ali Esmaeili-Nadimi
Journal:  Sci Rep       Date:  2022-07-07       Impact factor: 4.996

Review 3.  Factors Associated with Long-Term Retention in Buprenorphine-Based Addiction Treatment Programs: a Systematic Review.

Authors:  Amy J Kennedy; Charles B Wessel; Rebecca Levine; Kendall Downer; Megan Raymond; Deborah Osakue; Iman Hassan; Jessica S Merlin; Jane M Liebschutz
Journal:  J Gen Intern Med       Date:  2021-01-19       Impact factor: 5.128

Review 4.  Pharmacological therapies for management of opium withdrawal.

Authors:  Afarin Rahimi-Movaghar; Jaleh Gholami; Laura Amato; Leila Hoseinie; Reza Yousefi-Nooraie; Masoumeh Amin-Esmaeili
Journal:  Cochrane Database Syst Rev       Date:  2018-06-21

5.  The Prevalence of Substance use and Associated Risk Factors Among University Students in the City of Jahrom, Southern Iran.

Authors:  Seyed Taghi Heydari; Somayeh Izedi; Yaser Sarikhani; Navid Kalani; Ali Akbary; Abolfazl Miri; Mojtaba Mahmoodi; Maryam Akbari
Journal:  Int J High Risk Behav Addict       Date:  2015-06-20

6.  Opioid Substitution Treatment Using Buprenorphine for Management of Dependence on Natural Opioids: Case Series.

Authors:  Preethy Kathiresan; Atul Ambekar; Siddharth Sarkar
Journal:  Indian J Psychol Med       Date:  2019-11-11

7.  Effect of opium addiction on new and traditional cardiovascular risk factors: do duration of addiction and route of administration matter?

Authors:  Sedigheh Asgary; Nizal Sarrafzadegan; Gholam-Ali Naderi; Reza Rozbehani
Journal:  Lipids Health Dis       Date:  2008-11-03       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.